Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Finance Online.
April 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
May 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
5 | 6 | 7 | 8 | 9 | 10 | 11 |
12 | 13 | 14 | 15 | 16 | 17 | 18 |
19 | 20 | 21 | 22 | 23 | 24 | 25 |
26 | 27 | 28 | 29 | 30 | 31 |
June 2025
Mo | Tu | We | Th | Fr | Sa | Su |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 |
Press releases published on March 2, 2025

Initial Drill Results Prove Significant Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Copper Project in the Vicuña District, Chile
Initial drilling of the Potro SE target on Sobek North intersected a new polymetallic mineralized system: 17.4m at 0.72g/t gold Eq. including 3.0m at 2.39 g/t gold Eq and high silver, lead, zinc with indications of copper The drill hole ended in strongly …

Latin Metals Identifies Geophysical Anomalies at Cerro Bayo, Santa Cruz, Argentina
VANCOUVER, British Columbia, March 02, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. (“Latin Metals” or the “Company”) - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce the identification of significant geophysical anomalies at its Cerro Bayo project (“ …

Ellomay Capital Announces Execution of Project Finance Agreements for its 198 MW Solar Portfolio in Italy
Tel-Aviv, Israel, March 02, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, …

Acki Nacki Secures Over $6M in Preparation For Network Launch
SOFIA, Bulgaria, March 02, 2025 (GLOBE NEWSWIRE) -- GOSH, the core developer behind Acki Nacki, has announced today the successful completion of its pre-launch Node Sale, securing backing from validators including Kingsway Capital, Blockchain.com, Hack VC, …

CREEPZ Emerges from Stealth, Announces Flagship Games, Retail Drops & Major Partnerships
LOS ANGELES, March 02, 2025 (GLOBE NEWSWIRE) -- After operating under the radar, CREEPZ is officially emerging from stealth, transforming from a $400M+ NFT phenomenon into a full-scale entertainment brand. Backed by WME, major esports organizations, and …

Bybit Web3 Pioneers AI Agent Acceleration: Launches First AI-DOL Reality Competition with $1M Prize
DUBAI, United Arab Emirates, March 02, 2025 (GLOBE NEWSWIRE) -- Bybit Web3, the Web3 division of Bybit, is thrilled to accelerate AI innovation with the launch of its first AI-focused accelerator program - AI-DOL SUPERSTAR: Battle for Debut. This …

CGTN: How did China lay a good foundation for 2025 economic development
BEIJING, March 02, 2025 (GLOBE NEWSWIRE) -- CGTN publishes an article detailing how China prepared itself for economic growth in 2025 through a combination of targeted stimulus measures and high-level policy frameworks. China's economy has shown a …

TransPerfect Acquires Technicolor Games
SAN FRANCISCO and BANGALORE, India, March 01, 2025 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced it has acquired Technicolor Games, the gaming division of Technicolor Group, …

Merus gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 bekannt und berichtet über die Geschäftsentwicklung
- Phase-III-Zulassungsstudien zu Petosemtamab in Kombination mit Pembrolizumab in der Erstlinienbehandlung des PD-L1-positiven rezidivierten/metastasierten Kopf-Hals-Plattenepithelkarzinoms (r/m HNSCC) und Petosemtamab als Monotherapie in der Zweit-/ …

Merus annonce les résultats financiers de son quatrième trimestre et de l’ensemble de son exercice 2024, et fait le point sur ses activités
- Inclusion en cours pour les études d’enregistrement de phase III visant l’évaluation du pétosemtamab en association avec le pembrolizumab en traitement de 1ᵉ ligne pour un CETC r/m PD-L1 et l’évaluation du pétosemtamab en monothérapie de 2ᵉ et 3ᵉ ligne …